>アジア太平洋地域の細胞および遺伝子治療用解凍装置市場、モダリティ(ベンチトップ型およびポータブル型)、サンプル(細胞治療および遺伝子治療)、タイプ(手動解凍システムおよび自動解凍システム)、アプリケーション(上流処理および下流処理)、エンドユーザー(血液銀行および輸血センター、病院および診断研究所、研究研究所および学術機関、バイオテクノロジーおよび製薬業界、臍帯血および幹細胞バンク、遺伝子バンクなど)、流通チャネル(直接入札、第三者販売業者など)、国(中国、韓国、日本、インド、オーストラリア、シンガポール、マレーシア、インドネシア、タイ、フィリピン、その他のアジア太平洋地域)別の業界動向および2028年までの予測。
市場分析と洞察:アジア太平洋地域の細胞および遺伝子治療用解凍装置市場
細胞および遺伝子治療用解凍装置市場は、2021年から2028年の予測期間に市場成長を遂げると見込まれています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に14.2%のCAGRで成長し、2028年までに17億7,129万米ドルに達すると分析しています。心臓疾患、嚢胞性線維症、エイズなどの遺伝性疾患の増加により、高度な細胞および遺伝子治療用解凍装置が求められており、細胞および遺伝子治療用解凍装置市場の成長の原動力となっています。
技術の進歩により、細胞および遺伝子治療用解凍装置は、多くの主要市場プレーヤーが市場拡大のために新しいソリューションを開発し、発売するにつれて、簡単に利用できるようになりました。さらに、先進国だけでなく発展途上国でも医療費の増加が、細胞および遺伝子治療用解凍装置市場の成長を後押ししています。細胞および遺伝子治療用解凍装置市場は、慢性疾患の発生率の増加と技術の進歩により成長しています。
慢性疾患の罹患率の増加は、細胞および遺伝子治療用解凍装置市場の原動力となっています。細胞および遺伝子治療工学に関連するコストの上昇により、細胞および遺伝子治療用解凍装置の需要が低下し、細胞および遺伝子治療用解凍装置市場の成長が抑制されています。新しい技術進歩の急増は、細胞および遺伝子治療用解凍装置市場にとってチャンスとなっています。しかし、低所得国および中所得国でのアクセスの欠如は、細胞および遺伝子治療用解凍装置市場の成長にとって課題となっています。
細胞および遺伝子治療用解凍装置市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と細胞および遺伝子治療用解凍装置市場のシナリオを理解するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。
細胞および遺伝子治療用解凍装置市場の範囲と市場規模
細胞および遺伝子治療用解凍装置市場は、モダリティ、サンプル、タイプ、アプリケーション、エンドユーザー、流通チャネルに基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。
- サンプルに基づいて、細胞および遺伝子治療解凍装置市場は、細胞治療と遺伝子治療に分類されます。2021年には、がんの有病率と発生率の上昇により、細胞治療セグメントが細胞および遺伝子治療解凍装置市場を支配すると予想されます。
- タイプに基づいて、細胞および遺伝子治療用解凍装置市場は、手動解凍システムと自動解凍システムに分類されます。2021年には、再現性を向上させ、人的エラーを最小限に抑える自動解凍システムセグメントが細胞および遺伝子治療用解凍装置市場を支配すると予想されます。
- 用途に基づいて、細胞および遺伝子治療用解凍装置市場は、上流処理と下流処理に分類されます。2021年には、解凍システムの技術的進歩の高まりにより、上流処理セグメントが細胞および遺伝子治療用解凍装置市場を支配すると予想されます。
- エンドユーザーに基づいて、細胞および遺伝子治療解凍装置市場は、血液銀行および輸血センター、病院および診断研究所、研究室および学術機関、バイオテクノロジーおよび製薬業界、臍帯血および幹細胞バンク、遺伝子バンク、その他に分類されます。 2021年には、低所得国および中所得国における血液銀行と高度な医療提供者の増加により、血液銀行セグメントが細胞および遺伝子治療解凍装置市場を支配すると予想されます。
- 流通チャネルに基づいて、細胞および遺伝子治療解凍装置市場は、直接入札、サードパーティの販売代理店、その他に分類されます。 2021年には、医療提供者の大多数が直接入札から細胞および遺伝子治療解凍装置を調達するため、直接入札セグメントが細胞および遺伝子治療解凍装置市場を支配すると予想されます。
細胞および遺伝子治療用解凍装置市場の国別分析
細胞および遺伝子治療解凍装置市場は、モダリティ、サンプル、タイプ、アプリケーション、エンドユーザー、流通チャネルに基づいてセグメント化されています。
細胞および遺伝子治療用解凍装置市場レポートで取り上げられている国は、日本、インド、オーストラリア、シンガポール、マレーシア、インドネシア、タイ、フィリピン、およびその他のアジア太平洋諸国です。
中国はアジア太平洋市場の成長をリードしており、細胞および遺伝子治療の解凍装置プロバイダーの数が最も多いため、この国ではベンチトップセグメントが優勢となっています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
細胞および遺伝子治療用解凍装置に対する認知度を高めるための主要市場プレーヤーによる戦略的活動の拡大が、細胞および遺伝子治療用解凍装置市場の成長を後押ししています。
細胞および遺伝子治療用解凍装置市場では、特定の市場における各国の成長に関する詳細な市場分析も提供されます。さらに、市場プレーヤーの戦略と地理的なプレゼンスに関する詳細情報も提供されます。データは、2010 年から 2019 年までの履歴期間について利用可能です。
競争環境と細胞・遺伝子治療用解凍装置の市場シェア分析
細胞および遺伝子治療解凍装置市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線が含まれます。提供された上記のデータポイントは、細胞および遺伝子治療解凍装置市場に関連する会社の焦点にのみ関連しています。
細胞および遺伝子治療用解凍装置を扱っている主な企業としては、Pluristem Therapeutics Inc.、Genesis BPS、Eppendorf AG、Cytiva(Danaher Corporation の子会社)、Glenmark Pharmaceutical Inc.、USA(Glenmark の子会社)、EDGE pharma、Cook、SARSTEDT AG & Co. KG、Barkey、Boekel Scientific、LABCOLD、Sartorious AG、Helmer Scientific Inc. などがあり、その他国内企業も含まれています。DBMR のアナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供しています。
世界中の企業によって多くの契約や協定も開始されており、細胞および遺伝子治療の解凍装置市場も加速しています。
例えば、
- 2020 年 11 月、Eppendorg AG はインドで細胞解凍用 SmartBlock を発売しました。細胞解凍用 Smart Block は下流処理の基盤です。科学者にとって、あらゆる細胞処理ラボでの使用が簡単で便利です。
市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略は、細胞および遺伝子治療解凍装置市場における企業の足跡を強化し、組織の利益成長にも利益をもたらします。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES
5.1 UPSTREAM PROCESS
5.2 DOWNSTREAM PROCESS
6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT
7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS
7.1 CANADA
7.2 THE U.S.
7.3 EUROPE
7.4 GENE THERAPY LEGISLATION IN AUSTRIA
7.5 GENE THERAPY LEGISLATION IN BULGARIA
7.6 JAPAN
7.7 ITALY
7.8 MALAYSIA
8 REGIONAL SUMMARY
9 MARKET OVERVIEW
9.1 DRIVERS
9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA
9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES
9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD
9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS
9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS
9.2 RESTRAINTS
9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING
9.2.2 RISE OF UNWANTED MUTAGENS
9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS
9.2.4 STRICT REGULATORY FRAMEWORK
9.3 OPPORTUNITIES
9.3.1 INCREASING PREVALENCE OF CANCER
9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR
9.4 CHALLENGES
9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES
9.4.2 LACK OF ACCESSIBILITY
10 IMPACT OF COVID-19 ON ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
10.1 IMPACT ON PRICE
10.2 IMPACT ON DEMAND
10.3 IMPACT ON SUPPLY CHAIN
10.4 STRATEGIC DECISION FOR MANUFACTURERS
10.5 CONCLUSION
11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY
11.1 OVERVIEW
11.2 BENCH TOP
11.3 PORTABLE
12 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE
12.1 OVERVIEW
12.2 CELL THERAPIES
12.2.1 CAR T CELLS
12.2.2 NK CELLS
12.2.3 MSCS
12.2.4 TILS
12.2.5 OTHERS
12.3 GENE THERAPIES
12.3.1 ADENOVIRUS
12.3.2 ADENO-ASSOCIATED VIRUSES
12.3.3 LENTIVIRUSES
12.3.4 ONCOLYTIC VIRUSES
12.3.5 OTHERS
13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE
13.1 OVERVIEW
13.2 AUTOMATIC THAWING SYSTEM
13.3 MANUAL THAWING SYSTEM
14 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 UPSTREAM PROCESSING
14.2.1 AUTOMATIC THAWING SYSTEM
14.2.2 MANUAL THAWING SYSTEM
14.3 DOWNSTREAM PROCESSING
14.3.1 AUTOMATIC THAWING SYSTEM
14.3.2 MANUAL THAWING SYSTEM
15 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
15.3 BLOOD BANKS AND TRANSFUSION CENTERS
15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY
15.6 CORD BLOOD AND STEM CELL BANKS
15.7 GENE BANKS
15.8 OTHERS
16 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 THIRD PARTY DISTRIBUTORS
16.4 OTHERS
17 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION
17.1 ASIA-PACIFIC
17.1.1 CHINA
17.1.2 INDIA
17.1.3 JAPAN
17.1.4 SOUTH KOREA
17.1.5 AUSTRALIA
17.1.6 SINGAPORE
17.1.7 THAILAND
17.1.8 MALAYSIA
17.1.9 INDONESIA
17.1.10 PHILIPPINES
17.1.11 REST OF ASIA PACIFIC
18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 MERCK KGAA
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENTS
20.2 EPPENDORF AG
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.3 SARTORIUS AG
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 .RECENT DEVELOPMENTS
20.5 BARKEY
20.5.1 COMPANY SNAPSHOT
20.5.2 PRODUCT PORTFOLIO
20.5.3 RECENT DEVELOPMENTS
20.6 BOEKEL SCIENTIFIC
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 BIOLINE INDIA
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENTS
20.8 COOK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 GENESIS BPS
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 HELMER SCIENTIFIC INC.
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENTS
20.11 LABCOLD
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 PLEURISTEM THERAPEUTICS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 REVENUE ANALYSIS
20.12.3 PRODUCT PORTFOLIO
20.12.4 RECENT DEVELOPMENTS
20.13 SARSTEDT AG & CO. KG
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
表のリスト
TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 3 ASIA PACIFIC BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 ASIA PACIFIC PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 42 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 43 CHINA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 44 CHINA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 45 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 CHINA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 CHINA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 52 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 53 INDIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 54 INDIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 55 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 INDIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 INDIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 62 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 63 JAPAN CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 64 JAPAN GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 65 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 66 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 JAPAN UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 JAPAN DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 72 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH KOREA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 74 SOUTH KOREA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 75 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH KOREA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 SOUTH KOREA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 82 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 83 AUSTRALIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 84 AUSTRALIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 85 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 AUSTRALIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 AUSTRALIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 90 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 91 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 92 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 93 SINGAPORE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 94 SINGAPORE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 95 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 96 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 SINGAPORE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 98 SINGAPORE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 99 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 101 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 102 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 103 THAILAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 104 THAILAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 105 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 107 THAILAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 THAILAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 110 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 116 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 117 MALAYSIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 MALAYSIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 120 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 125 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 126 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 127 INDONESIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 INDONESIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 129 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 130 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 131 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 132 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 133 PHILIPPINES CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 134 PHILIPPINES GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 135 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 136 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 137 PHILIPPINES UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 PHILIPPINES DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 139 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 140 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
図表一覧
FIGURE 1 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028
FIGURE 15 PESTEL ANALYSIS
FIGURE 16 PORTERS FIVE FORCES MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES
FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE
FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)
FIGURE 21 ASIA PACIFIC CANCER INCIDENCE (2018)
FIGURE 22 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020
FIGURE 23 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 24 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 25 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020
FIGURE 27 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)
FIGURE 28 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)
FIGURE 29 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020
FIGURE 31 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)
FIGURE 32 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)
FIGURE 33 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 34 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020
FIGURE 35 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 36 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 37 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020
FIGURE 39 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 40 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 41 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 43 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 44 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 45 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)
FIGURE 47 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)
FIGURE 48 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)
FIGURE 51 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)
FIGURE 52 COMPANY SHARE ANALYSIS
FIGURE 53 COMPANY SHARE ANALYSIS
FIGURE 54 COMPANY SHARE ANALYSIS
FIGURE 55 COMPANY SHARE ANALYSIS
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。